Michael Griffin
Stock Analyst at Citigroup
(2.92)
# 1,642
Out of 5,072 analysts
15
Total ratings
100%
Success rate
26%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Michael Griffin
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| JLL Jones Lang LaSalle | Maintains: Neutral | $275 → $240 | $330.03 | -27.28% | 5 | May 28, 2025 | |
| CBRE CBRE Group | Maintains: Buy | $130 → $160 | $162.21 | -1.36% | 5 | Nov 25, 2024 | |
| AHR American Healthcare REIT | Initiates: Neutral | $14 | $50.50 | -72.28% | 1 | Mar 4, 2024 | |
| HR Healthcare Realty Trust | Maintains: Neutral | $19 → $17 | $18.28 | -7.00% | 2 | Aug 22, 2023 | |
| HPP Hudson Pacific Properties | Maintains: Neutral | $5 → $4.5 | $1.96 | +129.59% | 2 | May 19, 2023 |
Jones Lang LaSalle
May 28, 2025
Maintains: Neutral
Price Target: $275 → $240
Current: $330.03
Upside: -27.28%
CBRE Group
Nov 25, 2024
Maintains: Buy
Price Target: $130 → $160
Current: $162.21
Upside: -1.36%
American Healthcare REIT
Mar 4, 2024
Initiates: Neutral
Price Target: $14
Current: $50.50
Upside: -72.28%
Healthcare Realty Trust
Aug 22, 2023
Maintains: Neutral
Price Target: $19 → $17
Current: $18.28
Upside: -7.00%
Hudson Pacific Properties
May 19, 2023
Maintains: Neutral
Price Target: $5 → $4.5
Current: $1.96
Upside: +129.59%